321 related articles for article (PubMed ID: 20665374)
1. Chemokines in liver inflammation and fibrosis.
Wasmuth HE; Tacke F; Trautwein C
Semin Liver Dis; 2010 Aug; 30(3):215-25. PubMed ID: 20665374
[TBL] [Abstract][Full Text] [Related]
2. [Pathogenesis of liver fibrosis: modulation of stellate cells by chemokines].
Wasmuth HE; Weiskirchen R
Z Gastroenterol; 2010 Jan; 48(1):38-45. PubMed ID: 20072995
[TBL] [Abstract][Full Text] [Related]
3. Inflammation and hepatic fibrosis.
Bissell DM
Semin Liver Dis; 2010 Aug; 30(3):211-4. PubMed ID: 20665373
[No Abstract] [Full Text] [Related]
4. c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice.
Giebeler A; Boekschoten MV; Klein C; Borowiak M; Birchmeier C; Gassler N; Wasmuth HE; Müller M; Trautwein C; Streetz KL
Gastroenterology; 2009 Jul; 137(1):297-308, 308.e1-4. PubMed ID: 19208365
[TBL] [Abstract][Full Text] [Related]
5. The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection.
Zeremski M; Petrovic LM; Talal AH
J Viral Hepat; 2007 Oct; 14(10):675-87. PubMed ID: 17875002
[TBL] [Abstract][Full Text] [Related]
6. Chemokine-directed immune cell infiltration in acute and chronic liver disease.
Karlmark KR; Wasmuth HE; Trautwein C; Tacke F
Expert Rev Gastroenterol Hepatol; 2008 Apr; 2(2):233-42. PubMed ID: 19072358
[TBL] [Abstract][Full Text] [Related]
7. [Genetic risk factors for hepatic fibrosis in chronic liver diseases].
Wasmuth HE; Lammert F; Matern S
Med Klin (Munich); 2003 Dec; 98(12):754-62. PubMed ID: 14685677
[TBL] [Abstract][Full Text] [Related]
8. Reduced nicotinamide adenine dinucleotide phosphate oxidase mediates fibrotic and inflammatory effects of leptin on hepatic stellate cells.
De Minicis S; Seki E; Oesterreicher C; Schnabl B; Schwabe RF; Brenner DA
Hepatology; 2008 Dec; 48(6):2016-26. PubMed ID: 19025999
[TBL] [Abstract][Full Text] [Related]
9. Chemokines in hepatitis C virus infection: pathogenesis, prognosis and therapeutics.
Wald O; Weiss ID; Galun E; Peled A
Cytokine; 2007 Jul; 39(1):50-62. PubMed ID: 17629707
[TBL] [Abstract][Full Text] [Related]
10. Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver.
Shields PL; Morland CM; Salmon M; Qin S; Hubscher SG; Adams DH
J Immunol; 1999 Dec; 163(11):6236-43. PubMed ID: 10570316
[TBL] [Abstract][Full Text] [Related]
11. Cytokines and renin-angiotensin system signaling in hepatic fibrosis.
Moreno M; Bataller R
Clin Liver Dis; 2008 Nov; 12(4):825-52, ix. PubMed ID: 18984469
[TBL] [Abstract][Full Text] [Related]
12. Toll-like receptor 4 and hepatic fibrogenesis.
Pradere JP; Troeger JS; Dapito DH; Mencin AA; Schwabe RF
Semin Liver Dis; 2010 Aug; 30(3):232-44. PubMed ID: 20665376
[TBL] [Abstract][Full Text] [Related]
13. Chemokines as immune mediators of liver diseases related to the metabolic syndrome.
Berres ML; Nellen A; Wasmuth HE
Dig Dis; 2010; 28(1):192-6. PubMed ID: 20460910
[TBL] [Abstract][Full Text] [Related]
14. The fractalkine receptor CX₃CR1 protects against liver fibrosis by controlling differentiation and survival of infiltrating hepatic monocytes.
Karlmark KR; Zimmermann HW; Roderburg C; Gassler N; Wasmuth HE; Luedde T; Trautwein C; Tacke F
Hepatology; 2010 Nov; 52(5):1769-82. PubMed ID: 21038415
[TBL] [Abstract][Full Text] [Related]
15. Alcohol and liver fibrosis.
Cubero FJ; Urtasun R; Nieto N
Semin Liver Dis; 2009 May; 29(2):211-21. PubMed ID: 19387920
[TBL] [Abstract][Full Text] [Related]
16. Distinct patterns of chemokine expression are associated with leukocyte recruitment in alcoholic hepatitis and alcoholic cirrhosis.
Afford SC; Fisher NC; Neil DA; Fear J; Brun P; Hubscher SG; Adams DH
J Pathol; 1998 Sep; 186(1):82-9. PubMed ID: 9875144
[TBL] [Abstract][Full Text] [Related]
17. Roles for chemokines in liver disease.
Marra F; Tacke F
Gastroenterology; 2014 Sep; 147(3):577-594.e1. PubMed ID: 25066692
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic potential of chemokine receptor antagonists for liver disease.
Sahin H; Berres ML; Wasmuth HE
Expert Rev Clin Pharmacol; 2011 Jul; 4(4):503-13. PubMed ID: 22114859
[TBL] [Abstract][Full Text] [Related]
19. Chemokines and their receptors: orchestrating a fine balance between health and disease.
Sharma M
Crit Rev Biotechnol; 2010 Mar; 30(1):1-22. PubMed ID: 19780653
[TBL] [Abstract][Full Text] [Related]
20. Chemokines and Chemokine Receptors in the Development of NAFLD.
Roh YS; Seki E
Adv Exp Med Biol; 2018; 1061():45-53. PubMed ID: 29956205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
